Y-MABS THERAPEUTICS INC (YMAB) Stock Cash Flow
USA - NASDAQ:YMAB - US9842411095 - Common Stock
8.61 USD
+0.02 (+0.23%)
8.61 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.22M | -29.67M | -21.43M | -95.57M | -55.28M | |||
| Depreciation Amortization | 347.00K | 535.00K | 735.00K | 840.00K | 780.00K | |||
| Change In Working Capital | -8.47M | -3.65M | -19.73M | -10.37M | -7.28M | |||
| Taxes Paid | N/A | 713.00K | 367.00K | N/A | N/A | |||
| Other non cash items | 12.55M | 17.07M | 13.19M | 29.18M | -40.78M | |||
| OPERATING CASH FLOW | -17.80M | -15.71M | -27.23M | -75.92M | -102.56M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -970.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 62.01M | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | 0.00 | 61.04M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 2.41M | 4.31M | 100.00K | 80.00K | 108.31M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 2.41M | 4.31M | 100.00K | 80.00K | 108.31M | |||
| Exchange Rate Effect | N/A | N/A | 7.00K | 40.00K | 130.00K | |||
| CHANGE IN CASH | -15.51M | -11.40M | -27.13M | -75.80M | 66.92M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.80M | -15.71M | -27.23M | -75.92M | -102.56M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -970.00K | |||
| FREE CASH FLOW | -17.92M | -15.71M | -27.23M | -75.92M | -103.53M | |||
All data in USD